Respiratory distress syndrome (RDS), also known as Hyaline Membrane Disease (HMD), is the dominant clinical problem faced by preterm infants.
The greatest risk factor is low gestational age and the development of the disease begins with the impaired synthesis of pulmonary surfactant associated with prematurity.
The disease is exacerbated by treatable/preventable factors including
The diagnosis is made on the basis of the combination of clinical (grunting respirations, intercostals recession, nasal flaring, cyanosis and increased oxygen requirement) and radiological (diffuse reticulogranular pattern with air bronchograms) features.
The natural history is for the clinical signs to develop within 6 hours of life, with progressive worsening over the first 48 to 72 hours of life followed by recovery.
The condition can be prevented or the severity diminished by antenatal administration of betamethasone. The course of the disease is altered by exogenous surfactant therapy and assisted ventilation.
Signs and radiolological appearance of RDS are not specific and other causes of respiratory distress should be considered. In particular it is difficult to exclude sepsis as a possible diagnosis initially and antibiotic therapy should be given until blood cultures prove negative.
"Wet lung" and lung malformations as well as non-pulmonary causes of respiratory distress are uncommon in the preterm infant but should be excluded using the appropriate tests.
A chest xray is useful and should be performed in all cases of respiratory distress once the oxygen requirement exceeds 30%. The X-ray may need to be repeated if the illness runs a course that is unusual or protracted or the infant’s status suddenly worsens when air leak complications must be considered.
A full blood count and blood culture should be performed prior to starting antibiotics but antibiotics should not be withheld if blood sampling proves technically difficult. Antibiotics may be given intramuscularly in these circumstances.
Placing the infant in the lateral or prone posture rather than supine provides a clear airway. Repeated suctioning of the pharynx is not required and may cause apnoea and hypoxia.
Although both too much and too little oxygen are bad for preterm infants, hypoxia is much more dangerous over the short period of time while awaiting transport.
Monitoring
Arterial blood gases — accurate assessments can be made from samples taken from indwelling arterial lines which are usually performed in an intensive care setting, aiming to keep pO2 between 50 and 80 mm Hg. Assessment of oxygen requirements from arterial ‘stabs’ is not reliable.
Non-invasive monitoring — oxygen saturation monitors may be attached to the infant’s hand or foot. The desired range for infants less than 34 weeks gestation is 88 to 95% and for more mature infants 88 to 100%.
Cyanotic threshold — keep the ambient oxygen concentration 5 to 10% above the level at which the infant is noted to be cyanosed.
Administration
Oxygen concentrations up to 40% may be achieved through the oxygen port into an incubator. Above 40% is best achieved using warmed, humidified gas delivered via a headbox. Flow rates of at least 6-8 l/min are required to avoid rebreathing.
Indications
See Intubation Procedure section for further details.
Stabilization ventilator settings
For an infant with RDS reasonable settings are: ventilator rate 60 breaths per minute, inspiratory time 0.3 sec (expiratory time 0.7 sec), PEEP 5 cm and oxygen set to maintain saturations of 88 to 95%. Peak inspiratory pressure (PIP) should be set to achieve "reasonable" chest movement — usual intial settings in RDS will lie between 20 and 30 cm water.
Surfactant administration should be considered in any intubated infant with a presumed diagnosis of RDS.
In a spontaneously ventilating infant sudden deterioration may be caused by
Infants may be able to sustain the protracted tachypnoea associated with RDS for hours or days before developing respiratory failure. This may be signalled by onset of apnoea, sudden increase in oxygen requirements or very laboured respiratory efforts. Continued close monitoring throughout the infan's entire illness is mandatory.
In a ventilated infant sudden deterioration is most likely to be caused by
NCPAP vs endotracheal intubation and surfactant for infants with RDS.
Stabilization and transport of newborn infants and at-risk pregnancies 4th Edition 1998 NETS Publication
Neonatal-perinatal medicine: Diseases of the fetus and infant 6th ed 1997. Fanaroff AA and Martin RJ (eds). Mosby-Year Book.
The following reviews published in the Cochrane Library provide more detail on the evidence underlying
Greenough A, Milner AD, Dimitriou G. Synchronized mechanical ventilation for respiratory support in newborn infants (Cochrane Review). In: The Cochrane Library, Issue 2, 2001. Oxford: Update Software.
Soll RF. Synthetic surfactant for respiratory distress syndrome in preterm infants (Cochrane Review). In: The Cochrane Library, Issue 2, 2001. Oxford: Update Software.
Soll RF, Blanco F. Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome (Cochrane Review). In: The Cochrane Library, Issue 2, 2001. Oxford: Update Software.
Yost CC, Soll RF. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome (Cochrane Review). In: The Cochrane Library, Issue 2, 2001. Oxford: Update Software.
Please remember to read the disclaimer.
We welcome your Feedback.